Complement C4 is an Systemic Lupus Erythematosus (SLE)
Complement involvement in kidney diseases: From physiopathology to therapeutical targeting
Case report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation | BMC Nephrology | Full Text
A Review of Complement Activation in SLE | SpringerLink
Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro | The Journal of Rheumatology
Frontiers | Interpretation of Serological Complement Biomarkers in Disease
Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium | PLOS ONE
IJMS | Free Full-Text | Complement and Complement Targeting Therapies in Glomerular Diseases
Cell-bound complement activation products in SLE | Lupus Science & Medicine
SLE and Serum Complement: Causative, Concomitant or Coincidental?
Complement in Lupus Nephritis: The Good, the Bad, and the Unknown - ScienceDirect
Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity - Kim - 2019 - Arthritis & Rheumatology - Wiley Online Library
The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease | SpringerLink
Utilisation clinique du dosage du complément. En dosant le C3 et le C4... | Download Scientific Diagram
The complement system in lupus nephritis | F1000Research
Complement activation during an SLE (systemic lupus erythematosus)... | Download Scientific Diagram
The Role of Complement in SLE - ScienceDirect
SLE and Serum Complement: Causative, Concomitant or Coincidental?
Case report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation | BMC Nephrology | Full Text
![PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d4a8c77ff85aa1fdad67620b0aea7f1405127ed2/9-Figure1-1.png "PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar")
PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar
The Complement System in Systemic Lupus Erythematosus - ScienceDirect
Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium | PLOS ONE
Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis - eBioMedicine
Molecules | Free Full-Text | Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus
Complement C 3, Complement C 3 level (C3 Assay) -...
Complement C 3, Complement C 3 level (C3 Assay) -...
